122 results on '"Ouyang, Xuesong"'
Search Results
2. Preclinical pharmacology modeling of chimeric antigen receptor T therapies
3. Composition and Histone Substrates of Polycomb Repressive Group Complexes Change during Cellular Differentiation
4. A Critical Role for p27kip1 Gene Dosage in a Mouse Model of Prostate Carcinogenesis
5. In Vivo Pharmacology Models for Cancer Target Research
6. Editor's Note: Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer
7. Supplementary Fig.5 from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor
8. Data from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor
9. Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor
10. Supplementary Table S1 from Loss-of-Function of Nkx3.1 Promotes Increased Oxidative Damage in Prostate Carcinogenesis
11. MIAME Microarry Data URL from Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer
12. Data from Emergence of Androgen Independence at Early Stages of Prostate Cancer Progression in Nkx3.1; Pten Mice
13. Supplementary Figure 1 from Emergence of Androgen Independence at Early Stages of Prostate Cancer Progression in Nkx3.1; Pten Mice
14. Supplementary Figures 1-3, Tables 1-4 from Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer
15. Supplementary Figure S1 and Legends from Loss-of-Function of Nkx3.1 Promotes Increased Oxidative Damage in Prostate Carcinogenesis
16. Data from Prolonged Exposure to Reduced Levels of Androgen Accelerates Prostate Cancer Progression in Nkx3.1; Pten Mutant Mice
17. Supplementary Table 1 from Prolonged Exposure to Reduced Levels of Androgen Accelerates Prostate Cancer Progression in Nkx3.1; Pten Mutant Mice
18. A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology
19. A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology
20. Identification of an NKX3.1-G9a-UTY transcriptional regulatory network that controls prostate differentiation
21. A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology
22. Combinatorial Activities of Akt and B-Raf/Erk Signaling in a Mouse Model of Androgen-Independent Prostate Cancer
23. Abstract 1814: Generation and validation of a novel humanized TNFR2 mouse model for the evaluation of therapeutic TNFR2 antibody
24. Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research
25. Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model
26. Inhibition of telomerase in tumor cells by ribozyme targeting telomerase RNA component
27. A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology
28. Microarray and bioinformatic detection of novel and established genes expressed in experimental anti-Thy1 nephritis
29. Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
30. Abstract 1016: Transcriptomic analysis of bulk tissues of large PDX collection as a novel platform discovering new TME target/drug
31. Abstract A013: In-depth annotations of the world's largest patient tumor-derived xenogragft (PDX) library for cancer research and preclinical pharmacology evaluation
32. Abstract B209: Transcriptomic analysis of patient-derived xenografts reveals heterogeneity in human and mouse stroma/immune compartments
33. Isolating of Target Genes for NKX3.1 in Prostate Carcinogenesis
34. Isolation of Target Genes for NKX3.1 in Prostate Carcinogenesis
35. Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice
36. Experimental animal modeling for immuno-oncology
37. Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor
38. Abstract 3219: Prior vaccination is critical to PD1/PDL-1 treatment efficacy in a mouse breast cancer allograft
39. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology
40. Diacylglycerol Acyltransferase-1 (DGAT1) Inhibition Perturbs Postprandial Gut Hormone Release
41. Isolation of Target Genes for NKX3.1 in Prostate Carcinogenesis
42. Attenuation of Slc27a5 Gene Expression Followed by LC–MS Measurement of Bile Acid Reconjugation Using Metabolomics and a Stable Isotope Tracer Strategy
43. Differential gene expression during sex hormone-induced prostate carcinogenesis in the rat with emphasis on ID-1 gene and its role in human prostate cancer
44. BRAF Activation Initiates but Does Not Maintain Invasive Prostate Adenocarcinoma
45. Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer
46. Prolonged Exposure to Reduced Levels of Androgen Accelerates Prostate Cancer Progression in Nkx3.1; Pten Mutant Mice
47. Vitamin D Inhibits the Formation of Prostatic Intraepithelial Neoplasia in Nkx3.1; Pten Mutant Mice
48. Emergence of Androgen Independence at Early Stages of Prostate Cancer Progression in Nkx3.1; Pten Mice
49. Loss-of-Function of Nkx3.1 Promotes Increased Oxidative Damage in Prostate Carcinogenesis
50. A critical role forp27 kip1gene dosage in a mouse model of prostate carcinogenesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.